Taha Al-Juhaishi to Immunotherapy, Adoptive
This is a "connection" page, showing publications Taha Al-Juhaishi has written about Immunotherapy, Adoptive.
Connection Strength
1.347
-
Selecting the Optimal CAR-T for the Treatment of B-Cell Malignancies. Curr Hematol Malig Rep. 2021 02; 16(1):32-39.
Score: 0.665
-
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC. Curr Oncol. 2026 Jun 12; 33(6).
Score: 0.240
-
Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2025 Aug; 31(8):494-504.
Score: 0.224
-
CAR-T in B-Cell Lymphomas: The Past, Present, and Future. Clin Lymphoma Myeloma Leuk. 2022 04; 22(4):e261-e268.
Score: 0.174
-
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center. Bone Marrow Transplant. 2022 06; 57(6):1025-1027.
Score: 0.045